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1. Data {#sec1}
=======

The majority of primary lateral sclerosis and amyotrophic lateral sclerosis studies focus on the motor cortex and corticospinal tracts \[[@bib2], [@bib3], [@bib4], [@bib5]\]. In this dataset ([Table 1](#tbl1){ref-type="table"}) we present total intracranial volume, thalamus, hippocampus, amygdala, caudate, pallidum, putamen and accumbens nucleus volumes for 33 patients with primary lateral sclerosis, 100 patients with amyotrophic lateral sclerosis and 117 age and gender-matched healthy controls. Data for bilateral structures are presented separately. Additionally, we provide hippocampal subfield volume estimates for the CA1, CA2/3, CA4, fimbria, subiculum, hippocampal tail, molecular layer, dentate gyrus, and hippocampal-amygdala transition area (HATA). Accompanying clinical and demographic characteristics are presented to highlight that the patient groups were matched for age, gender and ALSFRS-r and differed in years of education and symptom duration. Raw subcortical volumetric data ([Fig. 1](#fig1){ref-type="fig"}) and raw hippocampal subfield characteristics ([Fig. 2](#fig2){ref-type="fig"}) are presented in box plots for each cohort. The estimated marginal means and standard error of subcortical structures adjusted for the relevant clinical, radiological and demographic variables (age, gender, education, total intracranial volume, symptom duration) are summarised in [Table 2](#tbl2){ref-type="table"}, and hippocampal subfield profiles are presented in [Table 3](#tbl3){ref-type="table"} using the same covariates. Based on estimated marginal means corrected for age, gender, total intracranial volumes and education, the comparative profile of the two patient groups are also illustrated in radar plots with reference to healthy controls. Contrary to our original paper \[[@bib1]\] where percentage change was presented as absolute values, here, '100%' represents the estimated marginal means of healthy controls as normative values and the concentric circles depict the selective atrophy profiles of the ALS and PLS cohorts ([Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}).Table 1Data categories and measures ALS = amyotrophic lateral sclerosis; ALSFRS-R = amyotrophic lateral sclerosis functional rating scale-revised; PLS = Primary lateral sclerosis; CA = Cornu Ammonis; GC-DG = granule cell layer of the dentate gyrus; HATA = hippocampus-amygdala transition area, Lt = Left, Rt = Right.Table 1Data categoriesSpecific measuresDemographic variablesAge (year)Gender (Male/Female)Years of education (years)Handedness (Rt/Lt)Clinical data for ALS and PLSSymptom duration (months)ALSFRS-R (max 48)Subcortical grey matter structure volumeshippocampus (mm^3^)amygdala (mm^3^)thalamus (mm^3^)nucleus accumbens (mm^3^)caudate nucleus (mm^3^)putamen (mm^3^)pallidum (mm^3^)Hippocampal subfield volumesCA1 (mm^3^)CA2/CA3 (mm^3^)CA4 (mm^3^)Fimbria (mm^3^)Subiculum (mm^3^)Molecular layer (mm^3^)GC-ML-DG (mm^3^)HATA (mm^3^)Fig. 1Subcortical grey matter volumes in primary lateral sclerosis (PLS), amyotrophic lateral sclerosis (ALS) and healthy controls (HC).Fig. 1Fig. 2Hippocampal subfield volumes in primary lateral sclerosis (PLS), amyotrophic lateral sclerosis (ALS) and healthy controls (HC). CA = Cornu Ammonis; GC-ML-DG = Granule Cell and Molecular Layer of the Dentate Gyrus; HATA = hippocampus-amygdala transition area.Fig. 2Table 2The demographic, clinical and subcortical grey matter profile of the three groups. ALSFRS-r = the revised ALS functional rating scale, EMM = estimated marginal mean, M = Mean, N/a = Not applicable, SE = standard error, SD = standard deviation. Estimate marginal means are adjusted with the following values age = 58.77, gender = 1.45, education = 13.78, and total intracranial volume = 1429699.38.Table 2PLS\
n = 33ALS\
n = 100Healthy Controls\
n = 117p valueAge M/SD60.5 (10.5)59.8 (11.2)57.4 (11.9)0.19Gender (M/F)19/1462/3856/610.11Education (years) M/SD12.9 (3.4)13.5 (3.2)14.3 (3.3)0.04Handedness (R/L)29/490/10109/80.55ALSFRS-r (max 48) M/SD34.4 (5.3)36.6 (7.5)N/a0.11Symptom Duration (months) M/SD121.76 (68.7)20.6 (14.3)N/a7.1E-16Total intracranial volume (mm^3^) M/SD1439675.5 (145614.1)1440623.0\
(149085.7)1417549.2 (128172.3)0.432Hippocampus (Left) EMM/SE3566.6 (84.4)3624.1 (48.5)3805.1 (45.1)0.007Hippocampus (Right) EMM/SE3707.4 (85.4)3739.1 (49.1)3888.5 (45.7)0.045Amygdala (Left) EMM/SE1189.4 (42.3)1124.0 (24.4)1213.9 (22.7)0.03Amygdala (Right) EMM/SE1144.2 (44.0)1111.2 (25.3)1178.8 (23.5)0.16Thalamus (Left) EMM/SE7044.0 (97.9)7376.1 (56.3)7614.0 (52.4)2E-6Thalamus (Right) EMM/SE6896.5 (81.5)7181.9 (52.6)7402.8 (48.9)5E-6Nucleus accumbens (Left) EMM/SE473.8 (19.6)465.8 (11.3)493.8 (10.5)0.19Nucleus accumbens (Right) EMM/SE326.9 (19.0)339.6 (10.9)378.2 (10.2)0.01Caudate nucleus (Left) EMM/SE3283.3 (60.0)3287.5 (34.5)3409.6 (32.1)0.02Caudate nucleus (Right) EMM/SE3412.4 (66.3)3506.8 (38.1)3576.7 (35.5)0.08Putamen (Left) EMM/SE4550.8 (82.3)4620.7 (47.3)4692.2 (44.0)0.27Putamen (Right) EMM/SE4625.6 (86.7)4674.1 (50.0)4741.9 (46.3)0.41Pallidum (Left) EMM/SE1733.7 (36.3)1751.6 (20.8)1773.1 (19.4)0.58Pallidum (Right) EMM/SE1713.7 (40.5)1775.4 (23.3)1779.5 (21.7)0.34Table 3The hippocampal profile of the three groups. ALSFRS-r = the revised ALS functional rating scale, EMM = estimated marginal mean, M = Mean, N/a = Not applicable, SE = standard error, SD = standard deviation. Estimate marginal means are adjusted with the following values age = 58.77, gender = 1.45, education = 13.78, and total intracranial volume = 1429699.38.Table 3PLS\
n = 33ALS\
n = 100Healthy Controls\
n = 117p valueCA1 (mm^3^) EMM/SE632.8 (10.8)642.2 (6.2)660.5 (5.8)0.03CA2/CA3 (mm^3^) EMM/SE214.1 (5.0)212.6 (2.9)227.6 (2.7)5.2E-4CA4 (mm^3^) EMM/SE254.6 (4.6)257.0 (2.6)270.0 (2.5)4.2E-4Fimbria (mm^3^) EMM/SE74.9 (2.9)75.6 (1.6)77.1 (1.5)0.72Subiculum (mm^3^) EMM/SE421.6 (7.4)428.9 (4.3)438.7 (4.0)0.08Molecular layer (mm^3^) EMM/SE559.5 (9.3)563.5 (5.4)589.3 (5.0)6.5E-4GC-ML-DG (mm^3^) EMM/SE292.3 (5.4)296.5 (3.1)311.8 (2.9)2.9E-4HATA (mm^3^) EMM/SE62.7 (1.5)62.2 (0.9)65.1 (0.8)0.04Fig. 3The subcortical volumetric profile of PLS and ALS with reference to healthy controls. Estimated marginal means of volumes were calculated for each structure with the following values age = 58.77, gender = 1.45, education = 13.78, and total intracranial volume = 1429699.38. The estimated marginal means of healthy controls represent 100%.Fig. 3Fig. 4The hippocampal volumetric profile of PLS and ALS with reference to healthy controls. Estimated marginal means of volumes were calculated for each structure with the following values age = 58.77, gender = 1.45, education = 13.78, and total intracranial volume = 1429699.38. The estimated marginal means of healthy controls represent 100%.Fig. 4

2. Experimental design, materials, and methods {#sec2}
==============================================

Following institutional ethics approval, patients were recruited from a national motor neuron disease clinic and data were acquired with a standardised protocol \[[@bib6]\]. Participating ALS patients were diagnosed according to the El Escorial research criteria and PLS patients were diagnosed according to the Gordon criteria. The protocol was specifically designed to characterise subcortical grey matter degeneration in PLS based on evidence of extra-motor involvement in other motor neuron diseases \[[@bib7], [@bib8], [@bib9], [@bib10], [@bib11]\]. T1-weighted images were acquired with a spatial resolution of 1 × 1 × 1mm and field of view of 256 × 256 × 160 mm using a 3D Inversion Recovery prepared Spoiled Gradient Recalled echo (IR-SPGR) sequence. Pulse sequence settings are as follows: repetition time (TR) = 8.5 ms, echo time (TE) = 3.9 ms, Inversion time (TI) = 1060 ms, flip angle = 8°, SENSE factor = 1.5 \[[@bib12]\]. Raw MRI data underwent thorough quality control before pre-processing. Following 'deskulling' and spatial registration, model based segmentation was used the estimate subcortical volumes using FSL-FIRST of the FMRIB\'s Software Library (FSL) \[[@bib13],[@bib14]\]. Raw volumetric data were recorded for the hippocampus, amygdala, thalamus, nucleus accumbens, caudate nucleus, putamen, and pallidum in each hemisphere. Subsequently, the hippocampus of each participant was segmented into cytologically-defined subfields using version 6.0 of the FreeSurfer image analysis suite to estimate volumes of the CA1, CA2/3, CA4, fimbria, subiculum, hippocampal tail, molecular layer, dentate gyrus, and the hippocampal-amygdala transition area \[[@bib15]\]. Analyses of covariance (ANCOVA) were used to explore intergroup volumetric differences using age, education, gender and TIV as covariates \[[@bib16],[@bib17]\]. PLS versus ALS contrasts were also corrected for symptom duration. To illustrate disease-specific volumetric traits in PLS and ALS, the estimated marginal means of each structure were plotted on radar charts with reference to healthy controls.
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